Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses.

Abstract

The ability of antibodies elicited against the rabies human diploid cell vaccine (HDCV) to neutralise European bat Lyssaviruses (EBLV types-1 and -2), Australian bat Lyssavirus and classical rabies virus (RABV) has been evaluated using modified fluorescent antibody virus neutralisation (mFAVN) assays. Ninety-six percent (48 of 50) of the human post… (More)

Topics

Cite this paper

@article{Brookes2005RabiesHD, title={Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses.}, author={Sharon M. Brookes and Graham Parsons and Nicholas S. Johnson and L M McElhinney and Anthony Richard Fooks}, journal={Vaccine}, year={2005}, volume={23 32}, pages={4101-9} }